Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)A Randomized, Placebo-Controlled, Double-Blind, Double Dummy Trial To Determine The Relative Effect Of Pm101 Versus Placebo And Amiodarone IV On Blood Pressure In Subjects With Stable Congestive Heart Failure
- First Posted Date
- 2008-08-21
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- Prism Pharmaceuticals
- Registration Number
- NCT00739193
A Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2007-07-17
- Last Posted Date
- 2017-09-08
- Lead Sponsor
- Prism Pharmaceuticals
- Target Recruit Count
- 342
- Registration Number
- NCT00502346
- Locations
- 🇨🇦
Anapharm, Montreal, Quebec, Canada
Relative Bioavailability of PM101 IV and Cordarone IV
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2017-09-08
- Lead Sponsor
- Prism Pharmaceuticals
- Registration Number
- NCT00420953
- Locations
- 🇨🇦
Anapharm, Montreal, Quebec, Canada
News
No news found